 | Vincerx Pharma, Inc. | |||
| NCM : VINC || Location: United States | ||||
$0.9-0.05 (-5.26%) |
0.53 M | 0.85 - 0.95 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.800 M |
| March 15, 2024 | 0.864 M |
| Feb. 29, 2024 | 0.442 M |
| Feb. 15, 2024 | 0.241 M |
| Jan. 31, 2024 | 0.344 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.37 | -0.23 | 38.50% |
| 09/30/2023 | -0.47 | -0.46 | 1.25% |
| 06/30/2023 | -0.61 | -0.52 | 14.56% |
| 03/31/2023 | -0.53 | -0.68 | -28.21% |
| 12/31/2022 | -0.63 | -0.65 | -3.62% |
VINC Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 21.413M | Shares Float | 17.614M |
| Short Float | 0.800M | Market Cap | 20.34M |
| Institution ownership | 40.77% | Insider ownership | 24.999% |
| Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.89 | Forward EPS | -0.94 |